Involvement of ERK and Protein Tyrosine Phosphatase
Signaling Pathways in EGCG-Induced Cyclooxygenase-2
Expression in Raw 264.7 Cells
- Affiliated Author(s)
- 박종욱; 권택규; 서성일
- Alternative Author(s)
- Park, Jong Wook; Kwon, Taeg Kyu; Suh, Seong Il
- Journal Title
- Biochemical and Biophysical Research Communications
- Issued Date
- Prostaglandins play regulatory roles in a variety of physiological and pathological processes in immune response and inflammation. Epigallocatechin-3-gallate (EGCG) is known to potent antitumor agent with antioxidant property. We first investigated the effect of EGCG on the production of prostaglandin E2 (PGE2) and the expression of cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of PGE2, using macrophage cell line, Raw264.7. Our results showed that COX-2 expression and PGE2 production are upregulated by EGCG treatment and that this induction of COX-2 is regulated in part at the transcriptional level. In addition, we demonstrated the signal transduction pathway of mitogen-activated protein kinase (MAP kinase) in EGCG-mediated COX-2 expression. The MEK inhibitor (PD098059) prevented EGCG-induced COX-2 expression, whereas sodium orthovanadate (protein-tyrosine phosphatase inhibitor) significantly enhanced COX-2 expression and PGE2 production. These results suggest that EGCG mediated COX-2 expression and PGE2 production is associated with the activation of both the ERK and protein-tyrosine phosphatase signaling pathways.
prostaglandin, COX-2 promoter
- Authorize & License
- Files in This Item:
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.